Hyglos
Latest round
- Series A
Last raised
- Aug 2005
Total raised
- $6M
Investors
- 5
About Hyglos
Hyglos AG specializes in endotoxin detection solutions, primarily catering to the pharmaceutical industry. The company was acquired by bioMerieux in March 2009 for an undisclosed sum. Founded in Germany, Hyglos operates its headquarters there.ENDONEXT™ Solutions provides advanced endotoxin detection assays specifically designed for pharmaceutical applications. Their primary products include recombinant Factor C (rFC) assays, which replace the traditional horseshoe crab blood harvesting method, ensuring high specificity and consistency across various testing scenarios. Additionally, the ENDOZYME® II GO STRIPS offer flexibility in sample usage for laboratories.ENDONEXT™ Solutions generates revenue through direct sales of its endotoxin detection products and related services to pharmaceuticals. Their B2B model includes sales of assay kits and validation services, supported by partnerships with leading pharmaceutical firms for ongoing technical assistance and routine testing.Hyglos AG aims to enhance its product line with upcoming innovations in endotoxin detection technologies, though specific launch dates are not detailed. The company plans to expand its market presence in North America and Asia-Pacific by 2025. The acquisition by bioMerieux is expected to further bolster these growth initiatives.
Who invested in Hyglos
5 investors across 1 round
See all investors in Hyglos
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Aug 23, 2005
Amount
$6M
Investors
Questions about Hyglos
Who invested in Hyglos?
Hyglos has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Hyglos raised?
Hyglos has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Hyglos last raise money?
Hyglos's most recent round on record is a Series A, in Aug 2005.
What does Hyglos do?
Hyglos AG specializes in endotoxin detection solutions, primarily catering to the pharmaceutical industry.
Where is Hyglos headquartered?
Hyglos is headquartered in Germany.
Which VCs invest in companies like Hyglos?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Hyglos's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Hyglos? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.